Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joann Aaron

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Current Opinion in Oncology|June 4, 2005
Patient-physician communication in oncology: past, present, and futureWalter F Baile, Joann Aaron
The American Journal of Medicine|January 28, 2010
Juice plus or toxicity plusAung Naing, Joann Aaron, Razelle Kurzrock
The Breast Journal|January 6, 2009
Breast cancer: unique communication challenges and strategies to address themPatricia A Parker, Joann Aaron, Walter F Baile
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2005
Silence is not golden: communicating with children dying from cancerEstela A Beale, Walter F Baile, Joann Aaron
Cancer Treatment Reviews|December 4, 2012
Targeting the molecular chaperone heat shock protein 90 (HSP90): lessons learned and future directionsDavid S Hong, Udai Banerji, Bahareh Tavana, et al.
Anticancer Research|April 3, 2014
Pediatric patients with refractory central nervous system tumors: experiences of a clinical trial combining bevacizumab and temsirolimusSarina A Piha-Paul, Sang Joon Shin, Tribhawan Vats, et al.
The American Journal of Surgical Pathology|May 16, 2006
Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomasHoward Colman, Caterina Giannini, Li Huang, et al.
Biochimica Et Biophysica Acta|June 27, 2002
A noncoding RNA regulates human protease-activated receptor-1 gene during embryogenesisNageswara R Madamanchi, Zhao Y Hu, Fengzhi Li, et al.
Journal of Cancer|February 18, 2011
Phase I Dose Escalation Study of Sodium Stibogluconate (SSG), a Protein Tyrosine Phosphatase Inhibitor, Combined with Interferon Alpha for Patients with Solid TumorsAung Naing, James M Reuben, Luis H Camacho, et al.
Cancer|August 10, 2005
The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumorsJ Matthew McDonald, Siew Ju See, Ivo W Tremont, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Opinion in Oncology|June 4, 2005
Patient-physician communication in oncology: past, present, and futureWalter F Baile, Joann Aaron
The American Journal of Medicine|January 28, 2010
Juice plus or toxicity plusAung Naing, Joann Aaron, Razelle Kurzrock
The Breast Journal|January 6, 2009
Breast cancer: unique communication challenges and strategies to address themPatricia A Parker, Joann Aaron, Walter F Baile
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2005
Silence is not golden: communicating with children dying from cancerEstela A Beale, Walter F Baile, Joann Aaron
Cancer Treatment Reviews|December 4, 2012
Targeting the molecular chaperone heat shock protein 90 (HSP90): lessons learned and future directionsDavid S Hong, Udai Banerji, Bahareh Tavana, et al.
Anticancer Research|April 3, 2014
Pediatric patients with refractory central nervous system tumors: experiences of a clinical trial combining bevacizumab and temsirolimusSarina A Piha-Paul, Sang Joon Shin, Tribhawan Vats, et al.
The American Journal of Surgical Pathology|May 16, 2006
Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomasHoward Colman, Caterina Giannini, Li Huang, et al.
Biochimica Et Biophysica Acta|June 27, 2002
A noncoding RNA regulates human protease-activated receptor-1 gene during embryogenesisNageswara R Madamanchi, Zhao Y Hu, Fengzhi Li, et al.
Journal of Cancer|February 18, 2011
Phase I Dose Escalation Study of Sodium Stibogluconate (SSG), a Protein Tyrosine Phosphatase Inhibitor, Combined with Interferon Alpha for Patients with Solid TumorsAung Naing, James M Reuben, Luis H Camacho, et al.
Cancer|August 10, 2005
The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumorsJ Matthew McDonald, Siew Ju See, Ivo W Tremont, et al.
Pageof 1